250. When You Should Worry About LDL Cholesterol with Mike Fave

Today, Paul and Mike unpack their opinions about lipids. They talk about true risk for cardiovascular disease, primary versus secondary prevention, lipid lowering drugs, and share their thoughts on a recent podcast episode with Peter Attia. *Produced by Mountain Valley Media 00:06:08 Blood markers & imaging techniques of metabolic function  00:14:38 Gene mutations 00:20:28 LDL & Plaque burden 00:27:23 Money in statins 00:31:38 Downsides of lowering LDL 01:21:23 The downsides of popular cholesterol lowering drugs 01:41:07 Should we fear heart attacks? 01:45:23 PCSK9 Inhibitors 01:52:43 Risk profile of Statins  01:53:02 Risk vs. reward of Ezetimibe 02:04:02 Primary vs. secondary prevention Resources: Debunking Sugar Claims: What Dr. Lustig Got Wrong On The Huberman Podcast: https://www.youtube.com/watch?v=JcEmSgbMfco&t=2933s Work With Mike: https://mikefave.com/

Om Podcasten

Throughout my training and practice as a physician I have come to one very disappointing conclusion: Western medicine isn’t helping people lead better lives. Now that I’ve realized this, I’ve become obsessed with understanding what makes us healthy or ill. I want to live the best life I can and I want to be able to share this knowledge with others so that they can do the same. This podcast is the result of my relentless search to understand the roots of chronic disease. I hope you’ll join me on this journey.